top of page
Screening of inFlammation to enable personalized Medicine
(Active funding for SciFiMed ended in 2025, but its impact continues.)
Together we reach the next level of diagnostics
Home: Welcome
Learn more
SciFiMed was a multi-disciplinary project and combined fundamental immunological research with novel nanomaterial-based material development translated into proof-of-principle diagnostics.
SciFiMed will revolutionize doctors’ ability to diagnose and treat severe inflammatory diseases plaguing millions of Europeans.
SciFiMed
INVESTIGATED the pathophysiology of the FH-protein family,
to enable
the DEVELOPMENT of personalized, radically new on-time diagnostics,
which allow
IMPROVED patient stratification for prospective cohort studies
to
UNDERSTAND complement-associated diseases.
bottom of page